- Home
- AGEN vs LNKS Comparison
AGEN vs LNKS Comparison
Compare AGEN & LNKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- LNKS
- Stock Information
- Founded
- AGEN 1994
- LNKS 1995
- Country
- AGEN United States
- LNKS Malaysia
- Employees
- AGEN N/A
- LNKS N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- LNKS
- Sector
- AGEN Health Care
- LNKS
- Exchange
- AGEN Nasdaq
- LNKS NYSE
- Market Cap
- AGEN 96.2M
- LNKS 105.7M
- IPO Year
- AGEN 2000
- LNKS 2024
- Fundamental
- Price
- AGEN $3.32
- LNKS $0.81
- Analyst Decision
- AGEN Buy
- LNKS
- Analyst Count
- AGEN 3
- LNKS 0
- Target Price
- AGEN $10.50
- LNKS N/A
- AVG Volume (30 Days)
- AGEN 357.6K
- LNKS 112.1K
- Earning Date
- AGEN 03-13-2025
- LNKS 01-01-0001
- Dividend Yield
- AGEN N/A
- LNKS N/A
- EPS Growth
- AGEN N/A
- LNKS N/A
- EPS
- AGEN N/A
- LNKS N/A
- Revenue
- AGEN $160,427,000.00
- LNKS $4,754,489.00
- Revenue This Year
- AGEN N/A
- LNKS N/A
- Revenue Next Year
- AGEN $26.02
- LNKS N/A
- P/E Ratio
- AGEN N/A
- LNKS N/A
- Revenue Growth
- AGEN 59.00
- LNKS N/A
- 52 Week Low
- AGEN $2.50
- LNKS N/A
- 52 Week High
- AGEN $19.69
- LNKS N/A
- Technical
- Relative Strength Index (RSI)
- AGEN 45.96
- LNKS N/A
- Support Level
- AGEN $3.09
- LNKS N/A
- Resistance Level
- AGEN $3.68
- LNKS N/A
- Average True Range (ATR)
- AGEN 0.25
- LNKS 0.00
- MACD
- AGEN -0.03
- LNKS 0.00
- Stochastic Oscillator
- AGEN 23.00
- LNKS 0.00
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About LNKS LINKERS INDUSTRIES LIMITED
Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.